Free Trial
NASDAQ:OMER

Omeros (OMER) Stock Price, News & Analysis

Omeros logo
$3.65 +0.19 (+5.49%)
Closing price 04:00 PM Eastern
Extended Trading
$3.68 +0.04 (+0.96%)
As of 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Omeros Stock (NASDAQ:OMER)

Key Stats

Today's Range
$3.44
$3.79
50-Day Range
$2.97
$6.81
52-Week Range
$2.95
$13.60
Volume
954,253 shs
Average Volume
737,350 shs
Market Capitalization
$213.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Moderate Buy

Company Overview

Omeros Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
72nd Percentile Overall Score

OMER MarketRank™: 

Omeros scored higher than 72% of companies evaluated by MarketBeat, and ranked 361st out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Omeros has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Omeros has only been the subject of 3 research reports in the past 90 days.

  • Read more about Omeros' stock forecast and price target.
  • Earnings Growth

    Earnings for Omeros are expected to grow in the coming year, from ($3.09) to ($1.73) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Omeros is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Omeros is -1.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Omeros' valuation and earnings.
  • Percentage of Shares Shorted

    24.15% of the float of Omeros has been sold short.
  • Short Interest Ratio / Days to Cover

    Omeros has a short interest ratio ("days to cover") of 13.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Omeros has recently increased by 3.21%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Omeros does not currently pay a dividend.

  • Dividend Growth

    Omeros does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    24.15% of the float of Omeros has been sold short.
  • Short Interest Ratio / Days to Cover

    Omeros has a short interest ratio ("days to cover") of 13.1, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Omeros has recently increased by 3.21%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Omeros has a news sentiment score of 1.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Omeros this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for OMER on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • MarketBeat Follows

    Only 1 people have added Omeros to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Omeros insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.90% of the stock of Omeros is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    48.79% of the stock of Omeros is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Omeros' insider trading history.
Receive OMER Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omeros and its competitors with MarketBeat's FREE daily newsletter.

OMER Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
See More Headlines

OMER Stock Analysis - Frequently Asked Questions

Omeros' stock was trading at $9.88 at the start of the year. Since then, OMER stock has decreased by 63.1% and is now trading at $3.65.

Omeros Corporation (NASDAQ:OMER) announced its earnings results on Thursday, May, 15th. The biopharmaceutical company reported ($0.65) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.05.
Read the conference call transcript
.

Omeros subsidiaries include these companies: Nura.

Top institutional investors of Omeros include Wealth Enhancement Advisory Services LLC (0.04%). Insiders that own company stock include Peter A Md Demopulos, Gregory A Md Demopulos and Arnold C Hanish.
View institutional ownership trends
.

Shares of OMER stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Omeros investors own include JPMorgan Chase & Co. (JPM), Visa (V), AbbVie (ABBV), Meta Platforms (META), NVIDIA (NVDA), QUALCOMM (QCOM) and Global X Nasdaq 100 Covered Call ETF (QYLD).

Company Calendar

Last Earnings
5/15/2025
Today
7/11/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:OMER
CIK
1285819
Employees
210
Year Founded
1994

Price Target and Rating

High Price Target
$36.00
Low Price Target
$9.00
Potential Upside/Downside
+397.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$156.82 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-59.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.16
Quick Ratio
1.16

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.15) per share
Price / Book
-1.15

Miscellaneous

Outstanding Shares
58,590,000
Free Float
51,035,000
Market Cap
$211.80 million
Optionable
Optionable
Beta
2.16

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:OMER) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners